In summary, it is clear that autoreactive CD4+ T cells with a Th1- or Th1*-, and, in pattern II MS patients, also Th2 cells as well as proinflammatory B cells play key roles in several steps of the autoimmune pathogenesis of MS. Here, CD4 is linked to myeloid sarcoma.